Search for a trial

A randomized phase III study to evaluate the efficacy of chemoimmunotherapy with the monoclonal antibody Campath-1H (Alemtuzumab) given in combination with 2-weekly CHOP versus 2-weekly CHOP alone in elderly patients with previously untreated systemic peripheral T-cell lymphomas

See C4

An Open-label, Multi-center, Phase 2 Study of Denosumab in Subjects with Giant Cell Tumor of Bone

The objective of the study is to evaluate the safety profile of denosumab in subjects with Giant Cell Tumor of bone.

SP versus CFP in Older Patients in Efficacy and Safety

The clinical result of the CFP prosthesis is equal to or better than the clinical results of the SPII prosthesis in patients with osteoarthritis above the age of 70.Secondary purpose:Is there a difference between the scores of the SPII and CFP total…

Randomized phase III trial in elderly patients with previously untreated symptomatic Multiple Myeloma comparing MP-Thalidomide (MP-Thal) followed by thalidomide maintenance versus MP-Lenalidomide (MP-Len) followed by maintenance with lenalidomide

To compare efficacy, safety and quality of life of MP-Thal followed by thalidomide maintenance versus MP-Len followed by maintenance with lenalidomide

A Phase III Randomised Double-blind Study Comparing Sorafenib With Placebo In Patients With Resected Primary Renal Cell Carcinoma at High or Intermediate Risk of Relapse

The revised aims of the SORCE trial are:1. Does up to three years of treatment with sorafenib increase DFS compared with placebo: a comparison of Arm C vs Arm A2. If the answer to question (i) is yes, does one year of sorafenib (Arm B) increase DFS…

Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors

Primary: To determine the pharmacokinetics of several clinically used targeted anti-cancer agents.Secondary: To examine the relationship between treatment response/toxicity and plasma (or intracellular) drug levels.To evaluate the specific influence…

Study on Pharmacokinetics of newly developed ANtiretroviral agents in HIV-infected pregNAnt women (PANNA)

This study has been transitioned to CTIS with ID 2024-515487-31-00 check the CTIS register for the current data. The primary objective of this study is to describe the pharmacokinetics of antiretroviral agents, for which no or limited available…